X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21547) 21547
Newsletter (710) 710
Book Chapter (89) 89
Magazine Article (89) 89
Dissertation (79) 79
Newspaper Article (38) 38
Book Review (12) 12
Conference Proceeding (10) 10
Book / eBook (8) 8
Web Resource (8) 8
Publication (7) 7
Reference (5) 5
Report (5) 5
Paper (4) 4
Government Document (2) 2
Journal / eJournal (2) 2
Transcript (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carbamazepine (14107) 14107
humans (12127) 12127
male (7156) 7156
female (6469) 6469
carbamazepine - therapeutic use (5049) 5049
adult (5029) 5029
clinical neurology (4167) 4167
epilepsy (3999) 3999
anticonvulsants - therapeutic use (3665) 3665
pharmacology & pharmacy (3411) 3411
middle aged (3327) 3327
epilepsy - drug therapy (3278) 3278
carbamazepine - adverse effects (2880) 2880
adolescent (2613) 2613
animals (2523) 2523
anticonvulsants - adverse effects (2487) 2487
antiepileptic drugs (2287) 2287
psychiatry (2220) 2220
child (2138) 2138
phenytoin (1909) 1909
anticonvulsants (1884) 1884
aged (1869) 1869
neurosciences (1819) 1819
carbamazepine - pharmacology (1680) 1680
drugs (1585) 1585
carbamazepine - administration & dosage (1572) 1572
lamotrigine (1494) 1494
seizures (1493) 1493
carbamazepine - blood (1458) 1458
drug therapy, combination (1454) 1454
analysis (1424) 1424
carbamazepine - analogs & derivatives (1405) 1405
drug interactions (1351) 1351
anticonvulsants - pharmacology (1269) 1269
dose-response relationship, drug (1248) 1248
treatment outcome (1241) 1241
rats (1237) 1237
environmental sciences (1227) 1227
valproic acid (1186) 1186
valproic acid - therapeutic use (1182) 1182
pharmaceuticals (1150) 1150
oxcarbazepine (1139) 1139
children (1105) 1105
anticonvulsants - administration & dosage (1093) 1093
child, preschool (1055) 1055
double-blind (1055) 1055
valproate (1034) 1034
pharmacokinetics (1003) 1003
neurology (972) 972
research (966) 966
bipolar disorder - drug therapy (932) 932
carbamazepine - pharmacokinetics (899) 899
drug therapy (899) 899
anticonvulsants - pharmacokinetics (869) 869
anticonvulsants - blood (803) 803
time factors (801) 801
phenytoin - therapeutic use (791) 791
bipolar disorder (765) 765
electroencephalography (752) 752
pediatrics (750) 750
pregnancy (740) 740
toxicology (715) 715
kinetics (706) 706
mice (702) 702
lithium (698) 698
medicine, general & internal (685) 685
efficacy (676) 676
therapy (650) 650
sodium valproate (646) 646
carbamazepine - chemistry (642) 642
risk factors (623) 623
seizures - drug therapy (618) 618
metabolites (607) 607
carbamazepine - metabolism (606) 606
valproic acid - adverse effects (604) 604
epilepsy - blood (595) 595
retrospective studies (595) 595
epilepsies, partial - drug therapy (587) 587
monotherapy (583) 583
care and treatment (579) 579
young adult (573) 573
infant (556) 556
gabapentin (544) 544
double-blind method (539) 539
chemistry, multidisciplinary (538) 538
removal (535) 535
topiramate (535) 535
metabolism (533) 533
engineering, environmental (528) 528
chemistry, analytical (522) 522
personal care products (514) 514
solubility (501) 501
follow-up studies (487) 487
valproic acid - pharmacology (471) 471
health aspects (454) 454
medicine & public health (450) 450
phenobarbital - therapeutic use (447) 447
risk (447) 447
drug administration schedule (444) 444
phenytoin - adverse effects (443) 443
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20445) 20445
German (582) 582
Spanish (446) 446
French (417) 417
Japanese (287) 287
Russian (160) 160
Portuguese (156) 156
Italian (129) 129
Polish (113) 113
Chinese (73) 73
Dutch (43) 43
Danish (36) 36
Hungarian (30) 30
Turkish (28) 28
Korean (26) 26
Czech (22) 22
Norwegian (22) 22
Swedish (18) 18
Finnish (15) 15
Hebrew (12) 12
Croatian (11) 11
Persian (10) 10
Serbian (10) 10
Slovak (7) 7
Romanian (4) 4
Arabic (3) 3
Lithuanian (3) 3
Ukrainian (3) 3
Bosnian (2) 2
Breton (1) 1
Bulgarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Science of the total environment, ISSN 0048-9697, 11/2019, Volume 689, p. 70
The role of dissolved organic matters (DOM) in the matrix of water on the degradation of refractory pharmaceutical has aroused broad concerns. However, The... 
Carbamazepine
Journal Article
Lancet neurology, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Applied catalysis. B, Environmental, ISSN 0926-3373, 02/2018, Volume 221, p. 329
Display Omitted 
Carbamazepine
Journal Article
Epilepsia (Copenhagen), ISSN 0013-9580, 01/2013, Volume 54, Issue 1, pp. 108 - 116
Journal Article
Toxicology letters, ISSN 0378-4274, 10/2017, Volume 280, pp. S241 - S241
Journal Article
Applied catalysis. B, Environmental, ISSN 0926-3373, 03/2017, Volume 202, p. 528
Display Omitted 
Carbamazepine
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 09/2016, Volume 511, Issue 2, pp. 1132 - 1132
Journal Article
Journal Article
Toxicology letters, ISSN 0378-4274, 10/2016, Volume 259, pp. S84 - S84
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2015, Volume 357, pp. e346 - e346
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2012, Volume 129, Issue 6, pp. 1562 - 1569.e5
Background Increasing studies have revealed that HLA alleles are the major genetic determinants of drug hypersensitivity; however, the underlying molecular... 
Allergy and Immunology | Stevens-Johnson syndrome | HLA | drug hypersensitivity | Carbamazepine | toxic epidermal necrolysis | MARKER | RISK | IMMUNOLOGY | OXCARBAZEPINE | CUTANEOUS ADVERSE-REACTIONS | PEPTIDES | ALLERGY | HYPERSENSITIVITY REACTIONS | HLA-B-ASTERISK-1502 ALLELE | ASSOCIATION | Stevens-Johnson Syndrome - immunology | HLA-B15 Antigen - chemistry | Humans | Middle Aged | Male | Young Adult | Carbamazepine - chemistry | Stevens-Johnson Syndrome - chemically induced | Lymphocyte Activation - immunology | HLA-B15 Antigen - genetics | Drug Hypersensitivity - genetics | Adult | Female | Child | T-Lymphocytes, Cytotoxic - immunology | Cell Line | Peptides - immunology | Models, Molecular | Carbamazepine - immunology | Antigen Presentation - immunology | Protein Binding - immunology | Stevens-Johnson Syndrome - genetics | Carbamazepine - adverse effects | Drug Hypersensitivity - immunology | Adolescent | HLA-B15 Antigen - metabolism | T-Lymphocytes - immunology | Aged | Medical colleges | Care and treatment | Anticonvulsants | Histocompatibility antigens | Lymphocytes | HLA histocompatibility antigens | Universities and colleges | T cells | Drugs | Hypersensitivity | Antigen processing | Cytotoxicity | Lymphocytes T | Toxic epidermal necrolysis | Molecular modelling | surface plasmon resonance | Site-directed mutagenesis | Drug metabolism | Histocompatibility antigen HLA | Mathematical models | Antigenic determinants
Journal Article
Applied catalysis. B, Environmental, ISSN 0926-3373, 10/2015, Volume 176-177, p. 120
Display Omitted 
Carbamazepine
Journal Article
Toxicology letters, ISSN 0378-4274, 10/2015, Volume 238, Issue 2, pp. S137 - S137
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 01/2015, Volume 478, Issue 1, p. 232
Display Omitted 
Carbamazepine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 12, pp. 1134 - 1143
Journal Article
Journal Article
Seizure (London, England), ISSN 1059-1311, 2013, Volume 22, Issue 7, pp. 528 - 536
Abstract Purpose Analysis of overall tolerability and neurological adverse effects (AEs) of eslicarbazepine acetate (ESL), lacosamide (LCM) and oxcarbazepine... 
Neurology | Oxcarbazepine | Eslicarbazepine | Adverse events | Antiepileptic drugs | Epilepsy | Lacosamide | ADULT PATIENTS | EFFICACY | SAFETY | CARBAMAZEPINE | TOXICITY | ADJUNCTIVE LACOSAMIDE | NEUROSCIENCES | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | CONTROLLED-TRIALS | THERAPY | REFRACTORY PARTIAL EPILEPSY | Humans | Anticonvulsants - administration & dosage | Dose-Response Relationship, Drug | Nervous System Diseases - epidemiology | Anticonvulsants - adverse effects | Dibenzazepines - therapeutic use | Acetamides - therapeutic use | Carbamazepine - administration & dosage | Sodium Channel Blockers - adverse effects | Sodium Channel Blockers - administration & dosage | Acetamides - adverse effects | Sodium Channel Blockers - therapeutic use | Nervous System Diseases - physiopathology | Dizziness - epidemiology | Diplopia - chemically induced | Dibenzazepines - administration & dosage | Diplopia - epidemiology | Carbamazepine - analogs & derivatives | Double-Blind Method | Risk Assessment | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Ataxia - epidemiology | Dibenzazepines - adverse effects | Randomized Controlled Trials as Topic | Carbamazepine - adverse effects | Nervous System Diseases - chemically induced | Ataxia - chemically induced | Acetamides - administration & dosage | Complications and side effects | Anticonvulsants | Analysis
Journal Article